FDA Says Actos May Raise Risk of Bladder Cancer
FDA Concludes Actos May be Linked to Bladder Cancer. The U.S. Food and Drug Administration (FDA) has concluded that pioglitazone, sold under the brand names Actos, Actoplus Met, Actoplus Met XR, Duetact and Oseni, may be associated with an increased risk of bladder cancer. The agency issued a Dec. 12, 2016 Safety … [Read more...] about FDA Says Actos May Raise Risk of Bladder Cancer
First Bellwether Trial Begins
Thousands Of Patients Developed Bladder Cancer The first Actos bellwether trial is moving forward and jury selection has taken place. Thousands of patients in the ongoing Actos litigation allege that they developed bladder cancer as a result of taking Actos (pioglitazone). Specifically, the couple who brought the case in the first … [Read more...] about First Bellwether Trial Begins
Man Diagnosed with Bladder Cancer after Taking Actos
Actos-Related Bladder Cancer. A Pennsylvania man has become the latest to claim that taking the type 2 diabetes drug Actos has resulted in him being stricken with bladder cancer. A lawsuit has been filed on his behalf in U.S. District Court for the Western District of Louisiana. The claim will be consolidated with other similar … [Read more...] about Man Diagnosed with Bladder Cancer after Taking Actos
Another lawsuit added to Actos bladder cancer MDL
Another Claim Added to Actos Bladder Malignancy MDL. A North Carolina man is the latest to claim that taking the popular type 2 diabetes drug Actos led to his bladder cancer diagnosis. He is being represented in his lawsuit by the national law firm of Parker Waichman LLP. The firm represents a growing number of … [Read more...] about Another lawsuit added to Actos bladder cancer MDL
PW Files Another Actos Bladder Cancer Lawsuit
Actos Bladder Cancer Lawsuit. Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit against Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli … [Read more...] about PW Files Another Actos Bladder Cancer Lawsuit
Actos Increases Bladder Cancer Risks
Actos Increases Bladder Cancer Risks. More bad news today for patients taking Actos (pioglitazone), as another study has found a link between the type 2 diabetes drug and bladder cancer. The research, published in the British Medical Journal, found that patients taking Actos are more than 80 percent more likely to develop bladder … [Read more...] about Actos Increases Bladder Cancer Risks
Actos Lawsuit Tidal Wave Expected
Actos Lawsuit Tidal Wave Expected. Plaintiffs' lawyers across the country are poised to file hundreds of Actos bladder cancer lawsuits, according to a report from the Associated Press. Over the past year, evidence linking Actos to bladder cancer has grown, and this summer, regulators in both Europe and the U.S. mandated stronger … [Read more...] about Actos Lawsuit Tidal Wave Expected
Actos Bladder Cancer Lawsuit Expected
Actos Bladder Cancer Lawsuit. Actos maker Takeda Pharmaceuticals can expect to be named in hundreds of bladder cancer lawsuits. Several plaintiffs lawyers recently told the Associated Press that their firms are preparing to file more than a hundred cases each, and they continue hear from more alleged Actos bladder cancer victims … [Read more...] about Actos Bladder Cancer Lawsuit Expected
Long-Term Actos Use May Increase Bladder Cancer Risk
Actos Bladder Cancer Risk Taking the diabetes drug Actos (pioglitazone) for more than a year could put users at risk for bladder cancer, according to a new Drug Safety Communication issued by the U.S. Food & Drug Administration (FDA). The FDA is advising doctors not to prescribe Actos to people with active bladder … [Read more...] about Long-Term Actos Use May Increase Bladder Cancer Risk
Consolidation Ordered for Actos Lawsuits
Actos Bladder Cancer Lawsuits. According to a release from the Judicial Panel on Multidistrict Litigation (JPML) announcing the formation of MDL for all federal lawsuits involving Actos’ link to bladder cancer, an initial 11 cases plus at least 100 more have now been consolidated before Judge Rebecca F. Doherty in the U.S. … [Read more...] about Consolidation Ordered for Actos Lawsuits
